186 related articles for article (PubMed ID: 35235156)
1. Nanosized paclitaxel-loaded niosomes: formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines.
Pourmoghadasiyan B; Tavakkoli F; Beram FM; Badmasti F; Mirzaie A; Kazempour R; Rahimi S; Larijani SF; Hejabi F; Sedaghatnia K
Mol Biol Rep; 2022 May; 49(5):3597-3608. PubMed ID: 35235156
[TBL] [Abstract][Full Text] [Related]
2. In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment.
Ahmadi S; Seraj M; Chiani M; Hosseini S; Bazzazan S; Akbarzadeh I; Saffar S; Mostafavi E
Int J Nanomedicine; 2022; 17():6233-6255. PubMed ID: 36531115
[TBL] [Abstract][Full Text] [Related]
3. The Optimized Formulation of Tamoxifen-Loaded Niosomes Efficiently Induced Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.
Akbarzadeh I; Farid M; Javidfar M; Zabet N; Shokoohian B; Arki MK; Shpichka A; Noorbazargan H; Aghdaei HA; Hossein-Khannazer N; Timashev P; Makvandi P; Vosough M
AAPS PharmSciTech; 2022 Jan; 23(1):57. PubMed ID: 35048234
[TBL] [Abstract][Full Text] [Related]
4. 3D-printing-assisted synthesis of paclitaxel-loaded niosomes functionalized by cross-linked gelatin/alginate composite: Large-scale synthesis and in-vitro anti-cancer evaluation.
Hosseini F; Mirzaei Chegeni M; Bidaki A; Zaer M; Abolhassani H; Seyedi SA; Nabipoorashrafi SA; Ashrafnia Menarbazari A; Moeinzadeh A; Farmani AR; Tavakkoli Yaraki M
Int J Biol Macromol; 2023 Jul; 242(Pt 1):124697. PubMed ID: 37156313
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
[TBL] [Abstract][Full Text] [Related]
6. Targeting Colorectal Cancer Cells with Niosomes Systems Loaded with Two Anticancer Drugs Models; Comparative In Vitro and Anticancer Studies.
El-Far SW; Abo El-Enin HA; Abdou EM; Nafea OE; Abdelmonem R
Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890115
[TBL] [Abstract][Full Text] [Related]
7. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
8. Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities.
Haddadian A; Robattorki FF; Dibah H; Soheili A; Ghanbarzadeh E; Sartipnia N; Hajrasouliha S; Pasban K; Andalibi R; Ch MH; Azari A; Chitgarzadeh A; Kashtali AB; Mastali F; Noorbazargan H; Mirzaie A
Sci Rep; 2022 Dec; 12(1):21938. PubMed ID: 36536030
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomes.
Barani M; Hajinezhad MR; Sargazi S; Rahdar A; Shahraki S; Lohrasbi-Nejad A; Baino F
J Mater Sci Mater Med; 2021 Dec; 32(12):147. PubMed ID: 34862910
[TBL] [Abstract][Full Text] [Related]
10. Super Magnetic Niosomal Nanocarrier as a New Approach for Treatment of Breast Cancer: A Case Study on SK-BR-3 and MDA-MB-231 Cell Lines.
Jamshidifar E; Eshrati Yeganeh F; Shayan M; Tavakkoli Yaraki M; Bourbour M; Moammeri A; Akbarzadeh I; Noorbazargan H; Hossein-Khannazer N
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360714
[TBL] [Abstract][Full Text] [Related]
11. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes.
Khan DH; Bashir S; Correia A; Khan MI; Figueiredo P; Santos HA; Peltonen L
Int J Pharm; 2019 Dec; 572():118764. PubMed ID: 31628977
[TBL] [Abstract][Full Text] [Related]
12. Novel Niosome-Encapsulated 2,5-Diketopiperazine (BHPPD): Synthesis, Formulation, and Anti-breast Cancer Activity.
Ghourchian H; Pecho RDC; Karimi-Dehkordi M; Mazandarani A; Ghajari G; Piri-Gharaghie T
Appl Biochem Biotechnol; 2024 Jun; 196(6):3126-3147. PubMed ID: 37624507
[TBL] [Abstract][Full Text] [Related]
13. Preparation of Artemisia Turcomanic Encapsulated Niosomal Nanocarriers and Evaluation of Anticancer Activities and Apoptosis Gene Expression Analysis in HeLa Cells.
Eslamian F; Keshtmand Z; Hesampour A
Chem Biodivers; 2023 May; 20(5):e202201160. PubMed ID: 37026601
[TBL] [Abstract][Full Text] [Related]
14. Co-encapsulation of hydrophilic and hydrophobic drugs into niosomal nanocarrier for enhanced breast cancer therapy: In silico and in vitro studies.
Amiri S; Pashizeh F; Moeinabadi-Bidgoli K; Eyvazi Y; Akbari T; Salehi Moghaddam Z; Eskandarisani M; Farahmand F; Hafezi Y; Nouri Jevinani H; Seif M; Mousavi-Niri N; Chiani M; Tavakkoli Yaraki M
Environ Res; 2023 Dec; 239(Pt 2):117292. PubMed ID: 37806480
[TBL] [Abstract][Full Text] [Related]
15. Niosomal delivery of simvastatin to MDA-MB-231 cancer cells.
Akbarzadeh I; Saremi Poor A; Yaghmaei S; Norouzian D; Noorbazargan H; Saffar S; Ahangari Cohan R; Bakhshandeh H
Drug Dev Ind Pharm; 2020 Sep; 46(9):1535-1549. PubMed ID: 32808813
[TBL] [Abstract][Full Text] [Related]
16. Enhanced nuclear translocation and activation of aryl hydrocarbon receptor (AhR) in THP-1 monocytic cell line by a novel niosomal formulation of indole-3-carbinol.
Abbaspour Sani N; Hasani M; Kianmehr A; Mohammadi S; Sheikh Arabi M; Yazdani Y
J Liposome Res; 2020 Jun; 30(2):117-125. PubMed ID: 30917715
[TBL] [Abstract][Full Text] [Related]
17. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
18. Preparing and assessing the physiochemical properties of curcumin niosomes and evaluating their cytotoxicity in 3T3 and MCF-7 cell lines.
Ashraf Ganjooei N; Ohadi M; Mostafavi SMA; Behnam B; Pardakhty A
Avicenna J Phytomed; 2021; 11(4):417-427. PubMed ID: 34290972
[TBL] [Abstract][Full Text] [Related]
19. Bioresponsive gingerol-loaded alginate-coated niosomal nanoparticles for targeting intracellular bacteria and cancer cells.
Pashizeh F; Mansouri A; Bazzazan S; Abdihaji M; Khaleghian M; Bazzazan S; Rezei N; Eskandari A; Mashayekhi F; Heydari M; Tavakkoli Yaraki M
Int J Biol Macromol; 2024 Feb; 258(Pt 2):128957. PubMed ID: 38154726
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of doxorubicin and paclitaxel via noisome nanocarriers attenuates cancerous phenotypes in gastric cancer cells.
Rezaei N; Kazem Arki M; Miri-Lavasani Z; Solhi R; Khoramipour M; Rashedi H; Asadzadeh Aghdaei H; Hossein-Khannazer N; Mostafavi E; Vosough M
Eur J Pharm Biopharm; 2023 Jul; 188():33-47. PubMed ID: 37105361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
